China Pharma Holdings Statistics
Total Valuation
CPHI has a market cap or net worth of $22.85 million. The enterprise value is $26.39 million.
Important Dates
The next estimated earnings date is Wednesday, May 13, 2026, after market close.
| Earnings Date | May 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
CPHI has 40.52 million shares outstanding. The number of shares has increased by 145.73% in one year.
| Current Share Class | 40.52M |
| Shares Outstanding | 40.52M |
| Shares Change (YoY) | +145.73% |
| Shares Change (QoQ) | +74.52% |
| Owned by Insiders (%) | 6.62% |
| Owned by Institutions (%) | 0.07% |
| Float | 37.84M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5.51 |
| Forward PS | n/a |
| PB Ratio | 0.38 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 256.93 |
| P/OCF Ratio | 154.12 |
| PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 6.37 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | 296.75 |
Financial Position
The company has a current ratio of 0.32, with a Debt / Equity ratio of 0.17.
| Current Ratio | 0.32 |
| Quick Ratio | 0.09 |
| Debt / Equity | 0.17 |
| Debt / EBITDA | n/a |
| Debt / FCF | 43.71 |
| Interest Coverage | -30.26 |
Financial Efficiency
Return on equity (ROE) is -20.91% and return on invested capital (ROIC) is -10.12%.
| Return on Equity (ROE) | -20.91% |
| Return on Assets (ROA) | -8.41% |
| Return on Invested Capital (ROIC) | -10.12% |
| Return on Capital Employed (ROCE) | -13.08% |
| Weighted Average Cost of Capital (WACC) | 9.04% |
| Revenue Per Employee | $19,276 |
| Profits Per Employee | -$14,826 |
| Employee Count | 215 |
| Asset Turnover | 0.18 |
| Inventory Turnover | 2.19 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -69.84% in the last 52 weeks. The beta is 1.09, so CPHI's price volatility has been similar to the market average.
| Beta (5Y) | 1.09 |
| 52-Week Price Change | -69.84% |
| 50-Day Moving Average | 0.61 |
| 200-Day Moving Average | 1.32 |
| Relative Strength Index (RSI) | 39.22 |
| Average Volume (20 Days) | 27,123 |
Short Selling Information
The latest short interest is 7,794, so 0.02% of the outstanding shares have been sold short.
| Short Interest | 7,794 |
| Short Previous Month | 9,158 |
| Short % of Shares Out | 0.02% |
| Short % of Float | 0.02% |
| Short Ratio (days to cover) | 0.27 |
Income Statement
In the last 12 months, CPHI had revenue of $4.14 million and -$3.19 million in losses. Loss per share was -$0.74.
| Revenue | 4.14M |
| Gross Profit | -131,950 |
| Operating Income | -3.09M |
| Pretax Income | -3.19M |
| Net Income | -3.19M |
| EBITDA | -1.58M |
| EBIT | -3.09M |
| Loss Per Share | -$0.74 |
Full Income Statement Balance Sheet
The company has $345,112 in cash and $3.89 million in debt, giving a net cash position of -$3.54 million or -$0.09 per share.
| Cash & Cash Equivalents | 345,112 |
| Total Debt | 3.89M |
| Net Cash | -3.54M |
| Net Cash Per Share | -$0.09 |
| Equity (Book Value) | 22.74M |
| Book Value Per Share | 1.47 |
| Working Capital | -5.05M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was $148,261 and capital expenditures -$59,324, giving a free cash flow of $88,937.
| Operating Cash Flow | 148,261 |
| Capital Expenditures | -59,324 |
| Depreciation & Amortization | 1.50M |
| Net Borrowing | -294,027 |
| Free Cash Flow | 88,937 |
| FCF Per Share | $0.00 |
Full Cash Flow Statement Margins
Gross margin is -3.18%, with operating and profit margins of -74.50% and -76.91%.
| Gross Margin | -3.18% |
| Operating Margin | -74.50% |
| Pretax Margin | -76.91% |
| Profit Margin | -76.91% |
| EBITDA Margin | -38.22% |
| EBIT Margin | -74.50% |
| FCF Margin | 2.15% |